Sign in to confirm you’re not a bot
This helps protect our community. Learn more

4th Annual ALS ONE Research Symposium Presentation:

ALS ONE
320 subscribers
122 views 3 years ago
Our 4th Annual ALS ONE Research Symposium was held on November 29th & 30th 2021, hosted by our research team: Dr’s Merit Cudkowicz, MD, MSc of MGH, Robert Brown, MD, DPhil of UMass Medical School, James Berry, MD, MPH of MGH, and Fernando Vieira, MD of ALS TDI. The conference had over 630 registered guests, including researchers, scientists, and members of the ALS community from around the world, convening virtually for two days of sharing critical research that is underway across the globe to help uncover therapeutic options leading to an ultimate cure for Amyotrophic Lateral Sclerosis (ALS). Recordings were made of the presentations which we are/were approved to share. IN THIS VIDEO: Symposium Segment: ALS Industry Presentations Presentation Title: Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS. Speaker: Shiran Zimri, PhD. of NeuroSense Therapeutics Moderated by: Robert H. Brown, Jr., D.Phil., M.D. ALS ONE is a 501c3 non-profit organization focused entirely on ALS research and care. To learn more about ALS ONE, visit: www.alsone.org ...more
...more
4th Annual ALS ONE Research Symposium Presentation:
3Likes
122Views
2021Dec 6
Our 4th Annual ALS ONE Research Symposium was held on November 29th & 30th 2021, hosted by our research team: Dr’s Merit Cudkowicz, MD, MSc of MGH, Robert Brown, MD, DPhil of UMass Medical School, James Berry, MD, MPH of MGH, and Fernando Vieira, MD of ALS TDI. The conference had over 630 registered guests, including researchers, scientists, and members of the ALS community from around the world, convening virtually for two days of sharing critical research that is underway across the globe to help uncover therapeutic options leading to an ultimate cure for Amyotrophic Lateral Sclerosis (ALS). Recordings were made of the presentations which we are/were approved to share. IN THIS VIDEO: Symposium Segment: ALS Industry Presentations Presentation Title: Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS. Speaker: Shiran Zimri, PhD. of NeuroSense Therapeutics Moderated by: Robert H. Brown, Jr., D.Phil., M.D. ALS ONE is a 501c3 non-profit organization focused entirely on ALS research and care. To learn more about ALS ONE, visit: www.alsone.org

Follow along using the transcript.

ALS ONE

320 subscribers